Smithbridge Asset Management’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $7.35M | Sell |
29,215
-2,369
| -8% | -$510K | 1% | 31 |
|
|
2026
Q1 | $6.87M | Sell |
31,584
-27,428
| -46% | -$6.08M | 1.02% | 32 |
|
|
2025
Q4 | $13.5M | Buy |
59,012
+18,364
| +45% | +$4.18M | 1.15% | 33 |
|
|
2025
Q3 | $9.41M | Sell |
40,648
-532
| -1% | -$108K | 1.37% | 27 |
|
|
2025
Q2 | $7.64M | Sell |
41,180
-1,658
| -4% | -$308K | 1.34% | 30 |
|
|
2025
Q1 | $8.98M | Buy |
+42,838
| New | +$8.33M | 1.66% | 20 |
|
|
2024
Q3 | $8.84M | Buy |
44,741
+283
| +0.6% | +$52.8K | 1.52% | 20 |
|
|
2024
Q2 | $7.63M | Sell |
44,458
-2,628
| -6% | -$435K | 1.58% | 19 |
|
|
2024
Q1 | $8.57M | Sell |
47,086
-1,383
| -3% | -$238K | 1.77% | 16 |
|
|
2023
Q4 | $7.51M | Sell |
48,469
-625
| -1% | -$91.1K | 1.71% | 12 |
|
|
2023
Q3 | $7.32M | Sell |
49,094
-665
| -1% | -$97.6K | 1.81% | 11 |
|
|
2023
Q2 | $6.7M | Buy |
49,759
+78
| +0.2% | +$11.4K | 1.57% | 17 |
|
|
2023
Q1 | $7.92M | Sell |
49,681
-263
| -0.5% | -$40.2K | 1.99% | 8 |
|
|
2022
Q4 | $8.07M | Buy |
49,944
+23,134
| +86% | +$3.55M | 2.15% | 6 |
|
|
2022
Q3 | $3.6M | Sell |
26,810
-598
| -2% | -$85.8K | 1.48% | 30 |
|
|
2022
Q2 | $4.2M | Buy |
27,408
+495
| +2% | +$75.6K | 1.62% | 25 |
|
|
2022
Q1 | $4.36M | Sell |
26,913
-108
| -0.4% | -$15.7K | 1.45% | 31 |
|
|
2021
Q4 | $3.66M | Sell |
27,021
-157
| -0.6% | -$18.5K | 1.11% | 37 |
|
|
2021
Q3 | $2.93M | Buy |
27,178
+257
| +1% | +$29.4K | 0.97% | 40 |
|
|
2021
Q2 | $3.03M | Buy |
26,921
+467
| +2% | +$52.6K | 0.99% | 39 |
|
|
2021
Q1 | $2.86M | Hold |
26,454
| – | – | 1.22% | 33 |
|
|
2020
Q4 | $2.83M | Sell |
26,454
-279
| -1% | -$26.8K | 1.31% | 32 |
|
|
2020
Q3 | $2.34M | Hold |
26,733
| – | – | 1.21% | 33 |
|
|
2020
Q2 | $2.63M | Sell |
26,733
-300
| -1% | -$26.4K | 1.46% | 32 |
|
|
2020
Q1 | $2.06M | Sell |
27,033
-1,600
| -6% | -$136K | 1.38% | 31 |
|
|
2019
Q4 | $2.54M | Buy |
28,633
+350
| +1% | +$29.1K | 1.31% | 33 |
|
|
2019
Q3 | $2.14M | Sell |
28,283
-500
| -2% | -$34.3K | 1.2% | 36 |
|
|
2019
Q2 | $2.09M | Hold |
28,783
| – | – | 1.21% | 36 |
|
|
2019
Q1 | $2.32M | Hold |
28,783
| – | – | 1.39% | 32 |
|
|
2018
Q4 | $2.65M | Buy |
28,783
+312
| +1% | +$27.4K | 1.86% | 24 |
|
|
2018
Q3 | $2.69M | Sell |
28,471
-395
| -1% | -$37.5K | 1.62% | 28 |
|
|
2018
Q2 | $2.67M | Sell |
28,866
-1,428
| -5% | -$139K | 1.71% | 24 |
|
|
2018
Q1 | $2.87M | Buy |
30,294
+546
| +2% | +$60K | 1.9% | 21 |
|
|
2017
Q4 | $2.88M | Buy |
29,748
+227
| +0.8% | +$21.4K | 1.82% | 23 |
|
|
2017
Q3 | $2.62M | Sell |
29,521
-800
| -3% | -$60.9K | 1.85% | 20 |
|
|
2017
Q2 | $2.2M | Sell |
30,321
-3,690
| -11% | -$248K | 1.81% | 26 |
|
|
2017
Q1 | $2.22M | Sell |
34,011
-400
| -1% | -$25.1K | 1.94% | 22 |
|
|
2016
Q4 | $2.15M | Hold |
34,411
| – | – | 1.9% | 25 |
|
|
2016
Q3 | $2.17M | Buy |
34,411
+121
| +0.4% | +$7.83K | 1.94% | 25 |
|
|
2016
Q2 | $2.12M | Hold |
34,290
| – | – | 1.97% | 24 |
|
|
2016
Q1 | $1.96M | Sell |
34,290
-2,800
| -8% | -$156K | 1.82% | 28 |
|
|
2015
Q4 | $2.2M | Sell |
37,090
-1,200
| -3% | -$69.1K | 2.02% | 26 |
|
|
2015
Q3 | $2.08M | Sell |
38,290
-1,200
| -3% | -$78.1K | 1.97% | 26 |
|
|
2015
Q2 | $2.65M | Buy |
39,490
+600
| +2% | +$39.2K | 2.23% | 24 |
|
|
2015
Q1 | $2.28M | Sell |
38,890
-300
| -0.8% | -$18.1K | 1.88% | 30 |
|
|
2014
Q4 | $2.56M | Sell |
39,190
-550
| -1% | -$34.7K | 2.1% | 24 |
|
|
2014
Q3 | $2.29M | Hold |
39,740
| – | – | 1.92% | 28 |
|
|
2014
Q2 | $2.24M | Sell |
39,740
-1,900
| -5% | -$99.7K | 1.89% | 28 |
|
|
2014
Q1 | $2.14M | Sell |
41,640
-1,350
| -3% | -$68.2K | 1.94% | 28 |
|
|
2013
Q4 | $2.27M | Sell |
42,990
-850
| -2% | -$41.8K | 2.08% | 25 |
|
|
2013
Q3 | $1.96M | Sell |
43,840
-260
| -0.6% | -$11.5K | 1.86% | 31 |
|
|
2013
Q2 | $1.82M | Buy |
+44,100
| New | +$1.93M | 1.84% | 28 |
|
Other funds holding ABBV
Smithbridge Asset Management's ABBV Position: Q2 2026 in Review
Smithbridge Asset Management reduced its AbbVie (ABBV) stake by 7.5% in Q2 2026, selling an estimated $510K and leaving 29,215 shares worth $7.35M. The position accounts for 1% of the portfolio, ranked #31.
Smithbridge Asset Management first reported a position in ABBV in Q2 2013 and has held it in 52 quarters since. The position peaked at $13.5M in Q4 2025. 2,236 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.
- Smithbridge Asset Management held 29,215 shares of AbbVie worth $7.35M as of Q2 2026.
- Smithbridge Asset Management sold 2,369 AbbVie shares in Q2 2026, an estimated $510K.
- AbbVie made up 1% of Smithbridge Asset Management's portfolio in Q2 2026, its #31 holding.
- Smithbridge Asset Management first reported a position in AbbVie in Q2 2013 and has held it in 52 quarters since.
- Smithbridge Asset Management's AbbVie position peaked at $13.5M in Q4 2025.
- 2,236 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.
Based on Smithbridge Asset Management's 13F filing for Q2 2026, filed 20 Jul 2026.